Publications by authors named "Zining Lei"

Claim this Profile
B
Branched-Chain α Keto-Acid Dehydrogenase Kinase-Mediated AKT Phosphorylation Promotes RCC Tumorigenesis and Drug Resistance.
Qin Tian, Jinxiang Wang, Qiji Li, Yangruiyu Liu, Yanping Chen, Zi-Ning Lei

Adv Sci (Weinh)· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
B-9-8, a Novel Harman Dimer, Reverses ABCG2-mediated Chemotherapeutic Drug Resistance.
Ruiqiang Zhao, Yan Wen, Chao-Yun Cai, Jing-Quan Wang, Pranav Gupta, Zi-Ning Lei

Recent Pat Anticancer Drug Discov· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tau is a receptor with low affinity for glucocorticoids and is required for glucocorticoid-induced bone loss.
Wenyu Fu, Meng Chen, Kaidi Wang, Yujianan Chen, Yazhou Cui, Zi-Ning Lei

Cell Res· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mobocertinib antagonizes multidrug resistance in ABCB1- and ABCG2-overexpressing cancer cells: In vitro and in vivo studies.
Xing-Duo Dong, Meng Zhang, Qiu-Xu Teng, Zi-Ning Lei, Chao-Yun Cai

Cancer Lett· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The correlation between cancer stem cells and epithelial-mesenchymal transition: molecular mechanisms and significance in cancer theragnosis.
Zi-Ning Lei, Qiu-Xu Teng, Jagadish Koya, Yangruiyu Liu, Zizhou Chen

Front Immunol· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
RN486, a Bruton's Tyrosine Kinase inhibitor, antagonizes multidrug resistance in ABCG2-overexpressing cancer cells.
Xing-Duo Dong, Qisi Lu, Yi-Dong Li, Chao-Yun Cai, Qiu-Xu Teng, Zi-Ning Lei

J Transl Int Med· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Overexpression of ABCC1 and ABCG2 confers resistance to talazoparib, a poly (ADP-Ribose) polymerase inhibitor.
Qiu-Xu Teng, Zi-Ning Lei, Jing-Quan Wang, Yuqi Yang, Zhuo-Xun Wu

Drug Resist Updat· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
ABCB1-dependent collateral sensitivity of multidrug-resistant colorectal cancer cells to the survivin inhibitor MX106-4C.
Zi-Ning Lei, Najah Albadari, Qiu-Xu Teng, Hadiar Rahman, Jing-Quan Wang

Drug Resist Updat· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Understanding and targeting resistance mechanisms in cancer.
Zi-Ning Lei, Qin Tian, Qiu-Xu Teng, John N D Wurpel, Leli Zeng

MedComm (2020)· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting GSTP1 as Therapeutic Strategy against Lung Adenocarcinoma Stemness and Resistance to Tyrosine Kinase Inhibitors.
Si-Qi Wang, Jun-Jiang Chen, Yuchen Jiang, Zi-Ning Lei, Ye Chun Ruan

Adv Sci (Weinh)· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Signaling pathways and therapeutic interventions in gastric cancer.
Zi-Ning Lei, Qiu-Xu Teng, Qin Tian, Wei Chen, Yuhao Xie

Signal Transduct Target Ther· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preclinical studies of the triazolo[1,5-]pyrimidine derivative WS-716 as a highly potent, specific and orally active P-glycoprotein (P-gp) inhibitor.
Sai-Qi Wang, Qiu-Xu Teng, Shuai Wang, Zi-Ning Lei, Hui-Hui Hu

Acta Pharm Sin B· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reconstruction of intestinal microecology of type 2 diabetes by fecal microbiota transplantation: Why and how.
Kaijian Hou, Shuo Zhang, Zezhen Wu, Dan Zhu, Fengwu Chen, Zi-Ning Lei

Bosn J Basic Med Sci· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Digoxin targets low density lipoprotein receptor-related protein 4 and protects against osteoarthritis.
Kai-di Wang, Xiang Ding, Nan Jiang, Chao Zeng, Jing Wu, Zi-Ning Lei, Guang-Hua Lei

Ann Rheum Dis· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Resistance of Cancer Cells to Palbociclib, a Cyclin-Dependent Kinase 4/6 Inhibitor, is Mediated by the ABCB1 Transporter.
Han Fu, Zhuo-Xun Wu, Zi-Ning Lei, Qiu-Xu Teng, Yuqi Yang, Yixiong Lei

Front Pharmacol· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PBK/TOPK inhibitor OTS964 resistance is mediated by ABCB1-dependent transport function in cancer: in vitro and in vivo study.
Yuqi Yang, Qiu-Xu Teng, Zhuo-Xun Wu, Jing-Quan Wang, Zi-Ning Lei

Mol Cancer· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
ABCB1 limits the cytotoxic activity of TAK-243, an inhibitor of the ubiquitin-activating enzyme UBA1.
Zhuoxun Wu, Yuqi Yang, Zining Lei, Silpa Narayanan, Jingquan Wang

Front Biosci (Landmark Ed)· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Overcoming multidrug resistance by knockout of ABCB1 gene using CRISPR/Cas9 system in SW620/Ad300 colorectal cancer cells.
Zi-Ning Lei, Qiu-Xu Teng, Zhuo-Xun Wu, Feng-Feng Ping, Peng Song

MedComm (2020)· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of the Triazolo[1,5-]Pyrimidine-Based Derivative WS-898 as a Highly Efficacious and Orally Bioavailable ABCB1 Inhibitor Capable of Overcoming Multidrug Resistance.
Shuai Wang, Sai-Qi Wang, Qiu-Xu Teng, Zi-Ning Lei, Zhe-Sheng Chen

J Med Chem· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
ATP-binding cassette (ABC) transporters in cancer: A review of recent updates.
Jing-Quan Wang, Zhuo-Xun Wu, Yuqi Yang, Qiu-Xu Teng, Yi-Dong Li, Zi-Ning Lei

J Evid Based Med· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Recent progress on targeting leukemia stem cells.
Xiang-Yu Ma, Liuya Wei, Zining Lei, Yanglu Chen, Zhiyong Ding

Drug Discov Today· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CMP25, a synthetic new agent, targets multidrug resistance-associated protein 7 (MRP7/ABCC10).
Jing-Quan Wang, Bo Wang, Qiu-Xu Teng, Zi-Ning Lei, Yi-Dong Li

Biochem Pharmacol· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Overexpression of ABCG2 Confers Resistance to MLN7243, a Ubiquitin-Activating Enzyme (UAE) Inhibitor.
Zhuo-Xun Wu, Yuqi Yang, Jing-Quan Wang, Silpa Narayanan, Zi-Ning Lei

Front Cell Dev Biol· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Insights on the structure-function relationship of human multidrug resistance protein 7 (MRP7/ABCC10) from molecular dynamics simulations and docking studies.
Jing-Quan Wang, Qingbin Cui, Zi-Ning Lei, Qiu-Xu Teng, Ning Ji

MedComm (2020)· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cabozantinib Reverses Topotecan Resistance in Human Non-Small Cell Lung Cancer NCI-H460/TPT10 Cell Line and Tumor Xenograft Model.
Zi-Ning Lei, Qiu-Xu Teng, Pranav Gupta, Wei Zhang, Silpa Narayanan

Front Cell Dev Biol· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis